课题基金 / 基金详情

q-Modulated Magnetic Resonance Imaging Contrast Agents

q-Modulated Magnetic Resonance Imaging Contrast Agents
q 调制磁共振成像造影剂
批准号:
8055544
负责人:
Thomas J Meade
金额:
$31.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-23 至 2014-06-30

项目摘要

项目成果

Thomas J Meade的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Summary/Abstract The goal of this project is to develop bioactivated magnetic resonance(MR) contrast agents for the imaging of in vivo processes, ranging from gene expression to secondary messenger activation. This project is focused on obtaining insights into the interrelated problems of developmental biology and clinical diseases by i. generating MR probes that function as real-time in vivo enzyme reporters, ii. Track gene expression in whole animals and correlate this information with ongoing developmental events, and iii. develop biocompatible scaffolds for the efficient delivery of these agents in experimental animals and potentially humans. In order to maximize the impact of this technique, functional contrast agents must be investigated and developed. Further, the study of developmental biology in whole animals will result in a deeper understanding of the role of spatial organization with mechanism. Therefore, to create an in vivo assay of enzymatic activities and detection of secondary messengers, MR contrast agents will be designed and synthesized with removable protection groups that largely prevent the access of water to a paramagnetic center. By limiting the access of bulk water (q- modulation) the unprocessed agent is designed to be an ineffective contrast agent. We have defined 5 primary objectives: 1.Synthesize and characterize MRI contrast agents with enzyme substrates as blocking groups of water (q-modulation) 2. Use computational modeling to direct synthetic efforts towards new q-modulated agents. 3.Develop targeted contrast agents and methods of amplifying the contrast signal. 4. Investigate delivery and the uptake mechanisms by which the agents are internalized by cells. 5. Evaluate the effectiveness of the agents in preclinical rodent models and other in vivo systems. Several tetraazamacrocyclic architectures will be synthesized and investigated. We will focus on the schematically represented structures I- V where the arrows represent the site of enzymatic attack for the irreversibly activated agents (I-III). PUBLIC HEALTH RELEVANCE: This project is relevant to public health because the results will directly impact current methods of diagnosis and treatment of clinical disease. The development of bioactivated contrast agents for tracking gene expression is a powerful tool for developmental biology which has wide-ranging applications in areas such as prevention of cancer metastasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Specific inhibition of transcription factors with Cobalt-Schiff Base Complexes
  • 批准号:
    9906254
  • 项目类别:
  • 资助金额:
    $29.36万
  • 财政年份:
    2017
  • 负责人:
    Thomas J Meade
  • 依托单位:
Co(III) Schiff base complexes as selective and irreversible inhibitors of MMP-2
  • 批准号:
    8512054
  • 项目类别:
  • 资助金额:
    $7.73万
  • 财政年份:
    2013
  • 负责人:
    Thomas J Meade
  • 依托单位:
Co(III) Schiff base complexes as selective and irreversible inhibitors of MMP-2
  • 批准号:
    8637018
  • 项目类别:
  • 资助金额:
    $7.49万
  • 财政年份:
    2013
  • 负责人:
    Thomas J Meade
  • 依托单位:
Steroid-Based Contrast Agents for Magnetic Resonance Imaging of Endocrine Disease
  • 批准号:
    8545175
  • 项目类别:
  • 资助金额:
    $32.44万
  • 财政年份:
    2012
  • 负责人:
    Thomas J Meade
  • 依托单位:
海外基金